Lennox-Gastaut syndrome – Talk Bio

Actionable Insights Powered by AI

Ovid Halts Preclinical Work and IV Seizure Program Following Soticlestat’s Phase 3 Setbacks

8 months ago talkbio0Tagged Dosage Forms, Infantile Severe Myoclonic Epilepsy, Lennox-Gastaut syndrome, Phase 3 trials, Preclinical, soticlestat, Takeda

Ovid Therapeutics, soticlestat, Phase 3 trials, Dravet syndrome, Lennox-Gastaut syndrome, preclinical work, IV seizure program, Takeda Pharmaceutical

Takeda’s Soticlestat Misses Main Goal in Two Pivotal Epilepsy Studies

10 months ago talkbio0Tagged Epilepsy, Infantile Severe Myoclonic Epilepsy, Lennox-Gastaut syndrome, Phase 3 trials, Seizures, soticlestat, Takeda, With frequency

Soticlestat, Takeda, Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Phase 3 Trials, Seizure Frequency